TXG

The current price of 10x Genomics, Inc. Class A Common Stock (TXG) is 64.85. Over the past 24 hours, the stock has changed by +0.92%. Follow the TXG chart for real-time price dynamics.

10x Genomics, Inc. Class A Common Stock trades under the ticker TXG. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

TXG has changed by +0.71% over the last week, +37.10% over the last month, and +369.25% over the last year. Review the chart to see whether the current move is part of a broader trend.

10x Genomics, Inc. Class A Common Stock currently has a market capitalization of 8.45 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

Last quarter, 10x Genomics, Inc. Class A Common Stock reported earnings of -0.14 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

10x Genomics, Inc. Class A Common Stock reported quarterly revenue of 151.04 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

10x Genomics, Inc. Class A Common Stock reported net income of -17.93 M for the last quarter. The previous quarter showed -13.47 M, which means net income changed by -33.12%.

As of the latest available data, 10x Genomics, Inc. Class A Common Stock has 1 178 employees. Workforce size can provide additional context about the company's scale and operations.

You can buy 10x Genomics, Inc. Class A Common Stock (TXG) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Investing in 10x Genomics, Inc. Class A Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the TXG chart and related analysis on metatrader.com as part of your research.